Technological advancements in immunoprecipitation techniques and increasing deployment in treatment of cancer and cardiovascular diseases expected to bolster market growth
The global immunoprecipitation market size is expected to reach USD 922.26 Million by 2028 and register a CAGR of 5.2% over the forecast period, according to the latest report by Reports and Data. Increasing research programs in pharmaceutical and biotechnology industries, rise in RD collaborations between academic institutes and pharmaceutical companies, and technological advancements in immunoprecipitation techniques are among some of the key factors fueling market revenue growth. Rising need for identifying antigens related to autoimmune diseases, surge in research activities in the areas of immunotherapy, genomics, drug development, and personalized medicine, and increased investments in biopharmaceutical research development activities are other factors supporting global market growth. Rising demand for advanced immunoprecipitation testing to treat cancer, cardiovascular diseases, and central nervous disorders is another major factor expected to fuel global immunoprecipitation market growth going ahead.
Immunoprecipitation (IP) refers to the technique that involves precipitation of a protein antigen using an antibody that binds to that particular protein. The process involves immobilization of a specific antibody to a solid support such as agarose resin or magnetic particles to purify the antigens. Immunoprecipitation is extensively used to isolate the target protein antigen and determine its structure, expression, and modification state. Co-immunoprecipitation (Co-IP), individual protein immunoprecipitation, Chromatin immunoprecipitation (ChIP), and RNA Immunoprecipitation (RIP) are the most widely used immunoprecipitation types. ChIP assays are used to identify DNA-binding proteins’ genomic regions, while RNA immunoprecipitation identifies RNA-binding proteins using techniques such as cDNA and RT-PCR sequencing.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC])@ https://www.reportsanddata.com/sample-enquiry-form/4000
Market Dynamics:
Growth in the historic period resulted from the rapid growth in the elderly population, strong economic growth in emerging markets, decline in oil prices, and health insurance reforms globally. Factors that negatively affected growth in the historic period were low healthcare access, shortages of skilled human resources, difficulty in manufacturing biologics, and regulatory changes.
Going forward, faster economic growth, technological developments and the increasing prevalence of diseases due to rising busy and sedentary lifestyles will drive the growth. Factors that could hinder the growth of this market in the future are rising interest rates, increasing awareness of alternative therapies and natural remedies, government provisions in healthcare services, and stringent government regulations.
Regional Outlook:
North America is the largest market for healthcare, followed by Asia-Pacific, Western Europe and then the other regions. Due to favorable regulations and policies in these regions, healthcare industry is rapidly growing. As the market in developed countries is nearly saturated, market players have shifted their focus toward the developing regions, especially the emerging economies of Asia Pacific.
Order this Reports @ https://www.reportsanddata.com/report-pricing/4000
Competitive Outlook:
The prominent factors favoring market growth include increasing launches and initiatives by the market players to provide rapid treatment for addressing the diseases of the patients in the healthcare industry. Market-trend-based strategies for the healthcare market include increasing the adoption of bundled payments, using digital tools, increasing collaborations across industries and companies, focusing on the development of new medicines, and adopting hybrid imaging technology. Players adopted strategies in the healthcare industry include acquiring companies in similar industries to expand their presence and focusing on offering quality products and services.
The competitive landscape section of the report discusses in detail the company overview, product and services portfolio, business expansion plans, production and manufacturing capacity, financial standing, and global market position. It further sheds light on the recent mergers and acquisitions, collaborations, partnerships, corporate and government deals, agreements, and product launches.
Top companies operating in the market and profiled in the report include:
Thermo Fisher Scientific, Abbkine Scientific Co. Ltd., Merck KGaA, Bio-Rad Laboratories, BioLegend, Cell Signaling Technology, Abcam, GenScript Biotech Corporation, Rockland Immunochemicals, Geno Technology, and Takara Bio.
Further, the report segments the Immunoprecipitation market on the basis of product types, applications, end-use industries, and technology among others. The report offers insights into key factors influencing the revenue growth of the segment and provides information about lucrative investment opportunities to stakeholders, investors, and clients.
Immunoprecipitation Market Segmentation:
By Type (Revenue, USD Million; 2018-2028)
- Individual protein immunoprecipitation
- Chromatin Immunoprecipitation (ChIP)
- Co-immunoprecipitation (Co-IP)
- RNA Immunoprecipitation (RIP)
- Others
By Product Type (Revenue, USD Million; 2018-2028)
- Kits
- Accessories
- Reagents
- Antibodies
- Primary Antibodies
- Secondary Antibodies
- Beads
- Agarose Beads
- Magnetic Beads
- Buffers
By End-use (Revenue, USD Million; 2018-2028)
- Pharmaceutical and Biopharmaceutical Companies
- Academic Research Institutes
- Contract Research Organizations (CROs)
- Others
Regional Analysis covers:
- North America
- S.
- Canada
- Mexico
- Europe
- Germany
- Italy
- K.
- Rest of EU
- Asia Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- Middle East Africa
- Saudi Arabia
- South Africa
- A.E
- Rest of MEA
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/4000
Thank you for reading our report. To know more about the customization feature, please get in touch with us and our team will ensure the report is customized to meet your requirements.
Explore More Industry Research by Reports and Data:
Peripheral Artery Disease Treatment Market @ https://images.google.co.uz/url?q=https://www.biospace.com/article/increase-awareness-of-benefits-of-pad-advanced-treatment-methods-is-expected-to-drive-peripheral-artery-disease-treatment-market-growth-by-2030-reports-and-data/
Netherton Syndrome Market @ https://images.google.co.uz/url?q=https://www.biospace.com/article/increased-awareness-of-the-netherton-syndrome-is-expected-to-drive-netherton-syndrome-market-growth-by-2030-reports-and-data/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
